Medimaps Group
Curated by SignalAdd-on software to DXA scanners for assessment of trabecular bone quality
Overview
Add-on software to DXA scanners for assessment of trabecular bone quality. The company has developed software for medical technologies to assess the quality of the trabecular bone. The FDA-cleared (K152299)TBS iNsight is a software that installs on any DXA scanners, which estimates the fracture risk based on a determination of bone texture, in addition to risks determined by DXA bone mineral density and clinical risk factors. The result is expressed as a Trabecular Bone Score (TBS).
Key facts
- Founded
- 2006
- Headquarters
- Wilmington, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 3 products and services
- Sign up to view
Contact
- Sign up to view
- Phone
- Sign up to view
Open roles
1 roleEvent Specialist
Texas, United States · Hybrid · Full-time